ZURA Zura Bio Ltd

Price (delayed)

$3.63

Market cap

$243.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.24

Enterprise value

$55.52M

zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven ...

Highlights
The company's equity has surged by 157% QoQ and by 127% YoY
The quick ratio has surged by 121% year-on-year and by 104% since the previous quarter

Key stats

What are the main financial stats of ZURA
Market
Shares outstanding
67.21M
Market cap
$243.96M
Enterprise value
$55.52M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.01
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$34.82M
EBITDA
-$34.82M
Free cash flow
-$18.24M
Per share
EPS
-$0.24
Free cash flow per share
-$0.24
Book value per share
$3.59
Revenue per share
$0
TBVPS
$2.53
Balance sheet
Total assets
$189.5M
Total liabilities
$17.44M
Debt
$0
Equity
$156.52M
Working capital
$174.4M
Liquidity
Debt to equity
0
Current ratio
12.57
Quick ratio
12.5
Net debt/EBITDA
5.41
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-23%
Return on equity
-32.9%
Return on invested capital
N/A
Return on capital employed
-20%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZURA stock price

How has the Zura Bio stock price performed over time
Intraday
-1.89%
1 week
1.11%
1 month
10.67%
1 year
-40.1%
YTD
-22.27%
QTD
3.71%

Financial performance

How have Zura Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$41.15M
Net income
-$34.82M
Gross margin
N/A
Net margin
N/A
ZURA's net income is up by 43% year-on-year and by 40% since the previous quarter
The operating income rose by 35% QoQ and by 31% YoY

Growth

What is Zura Bio's growth rate over time

Valuation

What is Zura Bio stock price valuation
P/E
N/A
P/B
1.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 100% year-on-year and by 83% since the previous quarter
The company's equity has surged by 157% QoQ and by 127% YoY
The price to book (P/B) is 62% less than the last 4 quarters average of 2.7

Efficiency

How efficient is Zura Bio business performance
Zura Bio's ROE has soared by 94% YoY and by 65% from the previous quarter
The return on assets has surged by 78% year-on-year and by 61% since the previous quarter

Dividends

What is ZURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ZURA.

Financial health

How did Zura Bio financials performed over time
Zura Bio's current ratio has surged by 121% YoY and by 104% QoQ
The quick ratio has surged by 121% year-on-year and by 104% since the previous quarter
The debt is 100% smaller than the equity
The company's equity has surged by 157% QoQ and by 127% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.